Table 1 Clinical features data for eight patients with FTPCD
From: Fovea-threatening and fovea-involving peripheral Coats disease: effects of posture and intervention
Management | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Patient/sex/age | Involved eye | VA at on Set | Leaking site | Sleeping position at on Set | Sleeping repositioning | Observation | Treatment | Follow up (monthos) | VA at outcome |
1/77444M/7 | OS | 20/20 | Inferior Temporal | Nasal | No | No | Laser+Antl-Vegf | 2 | CF |
2/ F/ 11 | OS | 20/20 | Inferior Temporal | Temporal | No | No | Laser+Antl-Vegf | 6 | CF |
3/M/11 | OS | 20/100 | Temporal | Nasal | Yes | Yes | Laser+Antl-Vegf | 12 | 20/30 |
4/M/34 | OS | 20/100 | Inferior Temporal | Nasal | Yes | Yes | Ozuroex | 1 | 20/30 |
5/F/62 | OS | 20/150 | Temporal | Nasal | Yes | Yes | Laser+Ozuroex | 6 | 20/40 |
6/F/39 | 0 | 20/60 | Inferior Temporal | Nasal | Yes | Yes | Laser + Antl-Vegf •ST STEROIO | 6 | 20/20 |
7/M/27 | 0 | 20/20 | Inferior Temporal | Nasal | Yes | Yes | Laser | 3 | 20/20 |
8/M/50 | OE | 20/40 | Inferior Temporal | Nasal | No | No | Laser + Antl-Vegf | 3 | 20/400 |